- Warsaw, Poland
- Hybrid
- Director
- Permanent
Provides medical and scientific leadership for pharmacovigilance and risk management of oncology assets in clinical development, interpreting safety data, detecting and escalating signals, and delivering benefit-risk recommendations. Represents Safety on cross-functional matrix teams and governance committees, and interacts with regulators and external experts. Hybrid role based in the UK with a global matrix environment.